Citadel Advisors
PPBT

Citadel Advisors’s Purple Biotech PPBT Stock Holding History

Citadel Advisors’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,250
Closed -$8.22K – 13951
2025
Q4 		$8.22K Buy
+1,250
New +$9.07K ﹤0.01% 12442
2024
Q3 		– Sell
-28
Closed -$2.32K – 14997
2024
Q2 		$2.32K Sell
28
-5
-15% -$580 ﹤0.01% 13701
2024
Q1 		$4.42K Buy
33
+1
+3% +$143 ﹤0.01% 13821
2023
Q4 		$4.91K Buy
32
+8
+33% +$1.77K ﹤0.01% 13470
2023
Q3 		$5.41K Sell
24
-21
-47% -$5K ﹤0.01% 13398
2023
Q2 		$12.6K Sell
45
-138
-75% -$49.5K ﹤0.01% 13071
2023
Q1 		$64.2K Sell
183
-146
-44% -$54.7K ﹤0.01% 11839
2022
Q4 		$90.8K Sell
329
-84
-20% -$32.2K ﹤0.01% 11352
2022
Q3 		$168K Buy
413
+344
+499% +$161K ﹤0.01% 10592
2022
Q2 		$33K Sell
69
-66
-49% -$39.5K ﹤0.01% 12170
2022
Q1 		$107K Sell
135
-1
-0.7% -$645 ﹤0.01% 12224
2021
Q4 		$105K Sell
136
-1
-0.7% -$852 ﹤0.01% 12670
2021
Q3 		$124K Sell
137
-125
-48% -$121K ﹤0.01% 12610
2021
Q2 		$256K Buy
262
+197
+303% +$181K ﹤0.01% 11648
2021
Q1 		$54K Buy
+65
New +$60.7K ﹤0.01% 12871

Other funds holding PPBT

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Citadel Advisors's PPBT Position: Q1 2026 in Review

Citadel Advisors sold out of Purple Biotech (PPBT) in Q1 2026, closing a stake of 4,274 shares — an estimated $28.1K sold.

Citadel Advisors first reported a position in PPBT in Q2 2016 and held it in 17 quarters. The position peaked at $400K in Q2 2020. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

  • Citadel Advisors reported no remaining Purple Biotech position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 4,274 Purple Biotech shares in Q1 2026, an estimated $28.1K.
  • Citadel Advisors first reported a position in Purple Biotech in Q2 2016 and held it in 17 quarters.
  • Citadel Advisors's Purple Biotech position peaked at $400K in Q2 2020.
  • 15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.